Home Cart Sign in  
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 304-20-1 Chemical Structure| 304-20-1

Structure of Hydralazine HCl
CAS No.: 304-20-1

Chemical Structure| 304-20-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Hydralazine HCl is a direct-acting vasodilator that is used as an antihypertensive agent.

Synonyms: Hydralazine (hydrochloride); 1-Hydrazinophthalazine; Nepresol

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Hydralazine HCl

CAS No. :304-20-1
Formula : C8H9ClN4
M.W : 196.64
SMILES Code : Cl.NNC1=NN=CC2=CC=CC=C12
Synonyms :
Hydralazine (hydrochloride); 1-Hydrazinophthalazine; Nepresol
MDL No. :MFCD00135998
InChI Key :ZUXNZUWOTSUBMN-UHFFFAOYSA-N
Pubchem ID :9351

Safety of Hydralazine HCl

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H301-H351-H361
Precautionary Statements:P201-P202-P264-P270-P281-P301+P310-P308+P313-P330-P405-P501
Class:6.1
UN#:2811
Packing Group:

Isoform Comparison

Biological Activity

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice Mouse model of Marfan syndrome Drinking water 16 mg/kg/day Started at the beginning of the third week of gestation and continued for 5 weeks To evaluate the protective effect of hydralazine on pregnancy-associated aortic dissection, results showed hydralazine significantly reduced the incidence of aortic dissection Sci Transl Med. 2019 May 1;11(490):eaat4822
Mice Surgically induced renal injury model Drinking water 0.001 mg/g/day Continued for 8 weeks To evaluate the effect of lowering blood pressure on cardiac hypertrophy, results showed no effect on the development of cardiac hypertrophy Kidney Int. 2009 Apr;75(8):800-8
Mice Angiotensin II-induced hypertension model Drinking water 320 mg/L Continuous administration To study the effect of hydralazine and hydrochlorothiazide on angiotensin II-induced hypertension, results showed that the combination therapy completely prevented the elevation of blood pressure and protected against aortic collagen deposition and stiffening. Circ Res. 2014 Feb 14;114(4):616-25.
Mice Hypertensive DOCA-salt mouse model Oral 25–30 mg/kg/d 12–14 days To evaluate the effect of hydralazine on diastolic dysfunction in hypertensive DOCA-salt mice. Results showed that hydralazine lowered blood pressure but did not improve diastolic dysfunction. Circulation. 2010 Feb 2;121(4):519-28
Mice Hypertension model Drinking water 250 mg/L Continuous administration for 14 days Hydralazine prevented the hypertension caused by angiotensin II and abrogated the increase in circulating activated T cells and vascular infiltration of leukocytes. Circ Res. 2010 Jul 23;107(2):263-70
CD-1 mice Remnant kidney model Oral administration via drinking water 250 mg/L Continuous administration for 4 weeks Reduced blood pressure but did not significantly slow CKD progression Kidney Int. 2010 Dec;78(11):1136-53

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT02884011 - Completed - United States, Illinois ... More >> Rush Univeristy Medical Center Chicago, Illinois, United States, 60612 Less <<
NCT03608085 Heart Failure Not Applicable Recruiting May 31, 2019 United States, Rhode Island ... More >> Ocean State Research Institute Recruiting Providence, Rhode Island, United States, 02908 Contact: Mary Ford    401-273-7100 ext 3674    Mary.Ford@va.gov    Principal Investigator: Tracey H Taveira, Pharm.D.          Sub-Investigator: Philip Haines, MD          Sub-Investigator: Wen-Chih Wu, MD          Providence VAMC Recruiting Providence, Rhode Island, United States, 02908 Contact: Melanie R Parent, Ba    401-273-7100 ext 6293    Melanie.Parent@va.gov    Principal Investigator: Tracey H Taveira, Pharm.D. Less <<
NCT03619317 - Recruiting August 2020 Denmark ... More >> University Hospital of Aarhus, Department of Cardiology Recruiting Aarhus N, Denmark, 8200 Contact: Mette Søndergaard    30130565    metast@rm.dk    Contact: Steen Poulsen       steen.hvitfeldt@rm.dk Less <<
NCT00683696 - Terminated - -
NCT00683696 Heart Failure ... More >> Ventricular Dyssynchrony Less << Phase 2 Phase 3 Terminated - -
NCT00283686 Kidney, Polycystic Phase 3 Completed - United States, Colorado ... More >> University of Colorado Health Sciences Center Denver (Aurora), Colorado, United States, 800045 United States, Georgia Emory University School of Medicine Atlanta, Georgia, United States, 30322 United States, Kansas University of Kansas Medical Center Kansas City, Kansas, United States, 66160 United States, Massachusetts Tufts University-New England Medical Center Boston, Massachusetts, United States, 02111 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, Ohio Cleveland Clinic Foundation Cleveland, Ohio, United States, 44195 Less <<
NCT00000620 - Completed - -
NCT00000620 Atherosclerosis ... More >> Cardiovascular Diseases Hypercholesterolemia Hypertension Diabetes Mellitus, Type 2 Diabetes Mellitus Coronary Disease Less << Phase 3 Completed - United States, Minnesota ... More >> Minneapolis Medical Research Foundation Minneapolis, Minnesota, United States, 55404 United States, New York Columbia University New York, New York, United States, 10027 United States, North Carolina Wake Forest University Winston-Salem, North Carolina, United States, 27106 United States, Ohio Case Western Reserve University Cleveland, Ohio, United States, 44106 United States, Tennessee Veterans Affairs Memphis, Tennessee, United States, 38104 United States, Washington University of Washington Seattle, Washington, United States, 98195 Canada, Ontario McMaster University Hamilton, Ontario, Canada Less <<
NCT01958801 Horner's Syndrome Not Applicable Completed - Korea, Republic of ... More >> Daegu Catholic University Medical Center Daegu, Korea, Republic of, 705-718 Less <<
NCT00582777 Hypertensive Renal Disease Phase 2 Phase 3 Completed - United States, Alabama ... More >> University of Alabama Birmingham, Alabama, United States, 35233 United States, California University of Southern California Los Angeles, California, United States, 90033 Charles Drew Medical College Los Angeles, California, United States, 90059 University of California at San Diego San Diego, California, United States, 92161 United States, Florida University of Florida Gainesville, Florida, United States, 32611 University of Miami Miami, Florida, United States, 33101 United States, Georgia Emory University Atlanta, Georgia, United States, 30308 United States, Illinois University of Chicago Chicago, Illinois, United States, 60637 United States, Maryland Johns Hopkins University Baltimore, Maryland, United States, 21205 United States, Michigan University of Michigan Ann Arbor, Michigan, United States, 48106 United States, New York Lenox Hill Hospital New York, New York, United States, 10021 United States, Ohio University Hospitals of Cleveland Cleveland, Ohio, United States, 44106 Ohio State University Columbus, Ohio, United States, 43210 United States, South Carolina Medical University of South Carolina Charleston, South Carolina, United States, 29425 United States, Tennessee Vanderbilt University Nashville, Tennessee, United States, 37232 United States, Texas Univesity of Texas Southwestern Medical Center at Dallas Dallas, Texas, United States, 75390 Less <<
NCT00661895 - Completed - -
NCT00226096 CVA (Cerebrovascular Accident)... More >> Cerebral Hemorrhage Intracranial Hemorrhages Less << Not Applicable Completed - Australia, New South Wales ... More >> Concord Hospital Concord, New South Wales, Australia, 2138 Gosford Hospital Gosford, New South Wales, Australia, 2250 St George Hospital Kogarah, New South Wales, Australia, 2217 John Hunter Hospital Newcastle, New South Wales, Australia, 2310 St Vincent's Hospital Sydney, New South Wales, Australia, 2010 Royal Prince Alfred Hospital Sydney, New South Wales, Australia, 2050 Westmead Hospital Westmead, New South Wales, Australia, 2145 Australia, South Australia Royal Adelaide Hospital Adelaide, South Australia, Australia, 5000 Australia, Victoria Royal Melbourne Hospital Melbourne, Victoria, Australia, 3050 St Vincent's Hospital Melbourne, Victoria, Australia, 3065 Box Hill Hospital Melbourne, Victoria, Australia, 3128 Alfred Hospital Melbourne, Victoria, Australia, 3181 Austin Health Melbourne, Victoria, Australia Monash Medical Centre Melbourne, Victoria, Australia Australia, Western Australia Sir Charles Gairdner Hospital Perth, Western Australia, Australia, 6009 China Regional Coordinating Centre: Peking University First Hospital Beijing, China, 100034 Hospitals in China, c/o The George Institute China Beijing, China Regional Coordinating Centre: Centre for Epidemiological Studies and Clinical Trials, Ruijin Hospital, Shanghai Institute of Hypertension, Shanghai Second Medical University Shanghai, China, 200025 New Zealand North Shore Hospital Auckland, New Zealand Christchurch Hospital Christchurch, New Zealand Less <<
NCT00661895 Hypertension Phase 4 Completed - United States, Nebraska ... More >> Creighton Community Health Center Omaha, Nebraska, United States, 68104 Less <<
NCT00283686 - Completed - -
NCT00512759 Acute Heart Failure Phase 4 Active, not recruiting December 2019 Brazil ... More >> Hospital Sao Paolo São Paulo, Brazil, 04024-002 Bulgaria 5-th Multifunctional Hospital for Active Treatment Sofia, Bulgaria National Transport Hospital "Tsar Boris III" Sofia, Bulgaria University Hospital "Tsaritsa Joanna-ISUL" Sofia, Bulgaria Germany University Hospital Mainz Mainz, Germany, 55131 Nuremberg Hospital Nuremberg, Germany, 90419 Spain Hospital Universitari Germans Trias i Pujol Badalona, Spain, 08916 Hospital de la Santa Creu i Sant Pau Barcelona, Spain, 08041 Switzerland University Hospital Basel Basel, BS, Switzerland, 4031 Kantonsspital Aarau Aarau, Switzerland, 5001 Kantonsspital Luzern Luzern, Switzerland, 6000 Kantonsspital St. Gallen St. Gallen, Switzerland, 9007 Less <<
NCT02592499 End-stage Heart Failure Not Applicable Recruiting December 2022 Sweden ... More >> Sahlgrenska Univesitetssjukhustet, Transplantationscentrum Recruiting Gothenburg, Sweden, 41234 Contact: Göran Dellgren    +46 31-342 88 63    goran.dellgren@vgregion.se    Linköping Univ Hospital Recruiting Linköping, Sweden Contact: Peter Wodlin, MD          Skåne University Hospital Recruiting Lund, Sweden Contact: Oscar Braun, MD          Karolinska Univ Hospital Recruiting Stockholm, Sweden Contact: Lars Lund, MD          Univ Hospital of Umeå Recruiting Umeå, Sweden Contact: Krister Lindmark, MD          Uppsala Univ Hospital Recruiting Uppsala, Sweden Contact: Ola Vedin, MD          Örebro Univ Hospital Recruiting Örebro, Sweden Contact: Barna Szado, MD Less <<
NCT03616730 - Not yet recruiting December 30, 2020 -
NCT03147092 Hypertension ... More >>Blood Pressure Less << Early Phase 1 Not yet recruiting June 30, 2021 -
NCT00716079 Intracerebral Hemorrhage ... More >> Stroke Hypertension Less << Not Applicable Completed - -
NCT00716079 - Completed - -
NCT00952081 Hypertension ... More >>Brain Tumor Epilepsy Less << Phase 4 Completed - United States, New York ... More >> NYU Langone Medical Center, Department of Anesthesiology New York, New York, United States, 10016 Less <<
NCT00952081 - Completed - -
NCT00684489 Hypertension Not Applicable Completed - -
NCT01422616 Ischemic Stroke ... More >> High Blood Pressure Less << Phase 3 Recruiting February 2019 Australia, New South Wales ... More >> Royal Prince Alfred Hospital Recruiting Sydney, New South Wales, Australia, 2050 Contact: Craig S Anderson, MD    +61 2 933 4500    canderson@georgeinstitute.org.au Less <<
NCT02620384 Acute Decompensated Heart Fail... More >>ure Less << Phase 3 Completed - United States, Ohio ... More >> Aultman Health Foundation Canton, Ohio, United States, 44710 Less <<
NCT00000499 Cardiovascular Diseases ... More >> Heart Diseases Hypertension Vascular Diseases Less << Phase 2 Completed - -
NCT02305095 - Recruiting June 2019 -
NCT03168529 Heart Failure Phase 4 Recruiting June 30, 2020 United States, Michigan ... More >> Wayne State University Recruiting Detroit, Michigan, United States, 48201 Contact: Phillip D Levy, MD, MPH    313-577-1214    plevy@med.wayne.edu    Contact: Patrick Medado    3137454621    pbmedado@med.wayne.edu    Henry Ford Hospital Not yet recruiting Detroit, Michigan, United States, 48202 Contact: David E Lanfear, MD, MS    313-916-5620    DLANFEA1@hfhs.org    Contact: Karen Leszczynski, RN    3139163502    Kleszcz2@hfhs.org Less <<
NCT00223717 Hypertension Phase 1 Completed - United States, Tennessee ... More >> Vanderbilt University Nashville, Tennessee, United States, 37232 Less <<
NCT00599235 Hypertension Not Applicable Completed - United Kingdom ... More >> University of Edinburgh - Western General Hospital Edinburgh, United Kingdom, EH4 2XU Less <<
NCT01041963 Continuous Ambulatory Peritone... More >>al Dialysis Less << Phase 4 Unknown September 2010 Thailand ... More >> Chulalongkorn university Recruiting Bangkok, Thailand, 10330 Contact: Talerngsak Kanjanabuch, Assist. Prf.    662-256-4321 ext 211    golfnephro@yahoo.com    Principal Investigator: Talerngsak Kanjanabuch, Assist. Prf.          Sub-Investigator: Wassawon Wontanatawatot, MD Less <<
NCT01255475 Heart Failure ... More >> Cardiac Failure Congestive Heart Failure Less << Phase 2 Phase 3 Completed - Brazil ... More >> Heart Institute (InCor) do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo São Paulo, SP, Brazil, 05403000 Less <<
NCT00772499 Hypertension Phase 4 Completed - United States, North Carolina ... More >> Wake Forest University Baptist Medical Center Winston-Salem, North Carolina, United States, 27157 Less <<
NCT02446652 Cervical Cancer Phase 3 Unknown August 2018 Mexico ... More >> National Institute of Cancerology Not yet recruiting Mexico City, DF, Mexico, 14080 Contact: Lucely Cetina, MD, MSc    +52 555 628 0400 ext 56101    micuentalucely@yahoo.com Less <<
NCT02522208 Heart Failure Phase 1 Completed - United States, Alabama ... More >> Pinnacle Research Group, LLC Anniston, Alabama, United States, 36207 United States, Florida Linfritz Research Institue Inc Coral Gables, Florida, United States, 33134 Jacksonville Center for Clinical Research Jacksonville, Florida, United States, 32216 United States, Georgia Morehouse School of Medicine Atlanta, Georgia, United States, 30310 United States, Rhode Island Center for Medical Research, LLC Providence, Rhode Island, United States, 02908 Less <<
NCT00204984 High Blood Pressure Not Applicable Completed - United States, Wisconsin ... More >> University of Wisconsin Hospital & Clinics Madison, Wisconsin, United States, 53792 Less <<
NCT01248169 - Completed - United States, Mississippi ... More >> Wiser Hospital for Women and Infants at the University of Mississippi Medical Center Jackson, Mississippi, United States, 39216 Less <<
NCT02281838 Intracerebral Hemorrhage Phase 2 Recruiting - Canada, Alberta ... More >> University of Alberta Recruiting Edmonton, Alberta, Canada, T6G 2B7 Contact: Ken S Butcher, MD, PhD    7804072171    ken.butcher@ualberta.ca    Principal Investigator: Ken S Butcher, MD, PhD          Canada, Ontario Ottawa Hospital Research Institute Recruiting Ottawa, Ontario, Canada, K1Y 4E9 Contact: Dar Dowlatshahi    613-761-4709    ddowlat@toh.on.ca    Principal Investigator: Dar Dowlatshahi, MD Less <<
NCT02046395 Type 2 Diabetes ... More >> Hypertension Less << Phase 4 Recruiting December 2019 United States, Louisiana ... More >> Tulane University Health Sciences Center Recruiting New Orleans, Louisiana, United States, 70112 Contact: Bonnie L Katalenich, MPH    504-988-0200    bkatalen@tulane.edu    Principal Investigator: Tina Thethi, MD, MPH Less <<
NCT00963976 Intracerebral Hemorrhage Phase 2 Completed - Canada, Alberta ... More >> University of Calgary Calgary, Alberta, Canada University of Alberta Edmonton, Alberta, Canada, T6G2B7 Grey Nuns Hospital Edmonton, Alberta, Canada, T6L 5X8 Canada, Ontario University of Ottawa Ottawa, Ontario, Canada Less <<
NCT02933593 Hypertension Not Applicable Withdrawn(PI withdrew the prot... More >>ocol) Less << - -
NCT00607477 Treatment Induced Hypertension Not Applicable Terminated(Study has been term... More >>inated due to poor accrual.) Less << - United States, Illinois ... More >> University of Chicago Chicago, Illinois, United States, 60637 Less <<
NCT01587313 Healthy Phase 1 Completed - United States, New Jersey ... More >> Frontage Cinical Services Hackensack, New Jersey, United States, 07601 Less <<
NCT01516346 Heart Failure ... More >> Congestive Heart Failure Less << Phase 2 Completed - United States, Pennsylvania ... More >> Philadelphia VA Medical Center Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT03514108 Heart Failure ... More >> Diabetes Less << Phase 4 Recruiting September 1, 2023 Denmark ... More >> Sygehus Sønderjylland, Aabenraa Not yet recruiting Aabenraa, Denmark Contact: Bartlomiej Jonczy          Aalborg University Hospital Not yet recruiting Aalborg, Denmark Contact: Søren Vraa          Aarhus University Hospital Recruiting Aarhus, Denmark Contact: Henrik Wiggers    +45 40136627    henrikwiggers@dadlnet.dk    Sub-Investigator: Anders Jorsal          Amager Hospital Not yet recruiting Copenhagen, Denmark Contact: Margrethe Ege Olsen          Bispebjerg Hospital Not yet recruiting Copenhagen, Denmark Contact: Olav Wendelbo Nielsen          Gentofte Hospital Recruiting Copenhagen, Denmark Contact: Morten Schou          Glostrup Hospital Not yet recruiting Copenhagen, Denmark Contact: Morten Petersen          Herlev Hospital Recruiting Copenhagen, Denmark Contact: Morten Schou          Hvidovre Hospital Not yet recruiting Copenhagen, Denmark Contact: Jens Hove          Rigshospitalet Recruiting Copenhagen, Denmark Contact: Lars Køber          Principal Investigator: Finn Gustafsson          Sydvestjysk Sygehus, Esbjerg Not yet recruiting Esbjerg, Denmark Contact: Kirsten Vilain Mikkelsen          Herning Hospital Not yet recruiting Herning, Denmark Contact: Morten Bøttcher          Regionshospital Nordjylland, Hjørring Not yet recruiting Hjørring, Denmark Contact: Gitte Nielsen          Holbæk Hospital Not yet recruiting Holbæk, Denmark Contact: Ilan Raymond          Horsens Hospital Not yet recruiting Horsens, Denmark Contact: Karen Kaae Dodt          Kolding Hospital Not yet recruiting Kolding, Denmark Contact: Monica Petronela Poenaru          Nykøbing Falster Hospital Not yet recruiting Nykøbing Falster, Denmark Contact: Lisbeth Tingsted          Odense University Hospital Not yet recruiting Odense, Denmark Contact: Mikael Kjær Poulsen          Sjællands Universitetshospital, Roskilde Not yet recruiting Roskilde, Denmark Contact: Nina Pernille Gardshodn Buch          Silkeborg Hospital Not yet recruiting Silkeborg, Denmark Contact: Anne Sejr Knudsen          Slagelse Sygehus Not yet recruiting Slagelse, Denmark Contact: Henrik Ryde          Vejle Hospital Not yet recruiting Vejle, Denmark Contact: Vibeke Brogaard          Viborg Hospital Not yet recruiting Viborg, Denmark Contact: Anne Pauline Schrøder Less <<
NCT01356875 Myelodysplastic Syndrome Phase 2 Unknown January 2015 Spain ... More >> Txagorritxu Hospital Not yet recruiting Vitoria-Gasteiz, Alava, Spain, 01009 Contact: Breno Moreno de Gusmao, MD    +34 945 007000    breno.morenodegusmao@osakidetza.net Less <<
NCT00607477 - Terminated(Study has been term... More >>inated due to poor accrual.) Less << - -
NCT00575640 Rectal Cancer Phase 1 Phase 2 Withdrawn(No enrollment) - -
NCT00404326 Cervical Cancer Phase 2 Completed - Mexico ... More >> National Institute of Cancerologia Mexico City, Tlalpan, Mexico, 14080 Less <<
NCT00532818 Metastatic Cervical Cancer Phase 3 Unknown December 2010 Mexico ... More >> Instituto Nacional de Cancerologia Recruiting Mexico City, Distrito Federal, Mexico, 14080 Principal Investigator: Lucely Cetina, MD Less <<
NCT02343393 Cardio-Renal Syndrome Phase 3 Unknown June 2016 Singapore ... More >> National University Hospital, Singapore Recruiting Singapore, Singapore, 119228 Contact: Shir Lynn Lim, MBBS, MRCP, MMed       shir_lynn_lim@nuhs.edu.sg    Principal Investigator: Shir Lynn Lim, MBBS, MRCP, MMed          National Heart Centre Singapore Not yet recruiting Singapore, Singapore, 169609 Contact: Kheng Leng David Sim, MBBS, MRCP, MS       david_sim@nhcs.com.sg    Principal Investigator: Kheng Leng David Sim, MBBS, MRCP, MS          Changi General Hospital Not yet recruiting Singapore, Singapore, 529889 Contact: Kui Toh Gerard Leong, MBBS, MRCP, MS       gerard_leong@cgh.com.sg    Principal Investigator: Kui Toh Gerard Leong, MBBS, MRCP, MS Less <<
NCT00395655 Locally Advanced Breast Cancer Phase 2 Terminated - Mexico ... More >> Instituto Nacional de Cancerologia Mexico City, Tlalpan, Mexico, 14080 Less <<
NCT00404508 Refractory Solid Tumors Phase 2 Completed - Mexico ... More >> National Institute of Cancerologia Mexico City, Tlalpan, Mexico, 14080 Less <<
NCT01538875 Hypertension, Pregnancy Induce... More >>d Less << Phase 3 Completed - Panama ... More >> Saint Thomas Maternity Hospital Panama, Panama Less <<
NCT03423810 Polycystic Kidney Diseases Early Phase 1 Recruiting May 15, 2019 United States, Kansas ... More >> University of Kansas Medical Center Recruiting Kansas City, Kansas, United States, 66160 Less <<
NCT00996060 Lung Cancer Phase 1 Completed - United States, New Mexico ... More >> University of New Mexico Cancer Center Albuquerque, New Mexico, United States, 87106 Less <<
NCT02228408 Chronic Hemodialysis (ESRD) Phase 4 Recruiting December 15, 2020 United States, Massachusetts ... More >> Brigham & Women's Hospital Recruiting Boston, Massachusetts, United States, 02115 Principal Investigator: David Charytan, MD Less <<
NCT00575978 Breast Cancer Phase 1 Phase 2 Withdrawn(IRB request) December 2009 -
NCT02050529 Hypertension, Pregnancy Induce... More >>d Hydralazine Adverse Reaction Pre-eclampsia Pre-eclampsia Superimposed Pre-existing Hypertension Less << Phase 2 Completed - Pakistan ... More >> Civil Hospital Karachi Karachi, Sindh, Pakistan, 74200 Less <<
NCT01822808 Acute Heart Failure ... More >> Left Ventricular Dysfunction Less << Phase 3 Unknown July 2016 South Africa ... More >> Hatter Institute for Cardiovascular Research in Africa Cape Town, Western Cape, South Africa, 7925 Less <<
NCT00533299 Ovarian Cancer Phase 3 Unknown December 2009 Mexico ... More >> Instituto Nacional de Cancerologia Recruiting Mexico City, Tlalpan, Mexico, 14080 Principal Investigator: Dolores Gallardo, MD Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

5.09mL

1.02mL

0.51mL

25.43mL

5.09mL

2.54mL

50.85mL

10.17mL

5.09mL

References

 

Historical Records

Categories